NCT04323241 is a NA clinical trial of Controlled cord traction in Cesarean Section Complications, sponsored by Haydarpasa Numune Training and Research Hospital.

Who is sponsoring NCT04323241?

NCT04323241 is sponsored by Haydarpasa Numune Training and Research Hospital.

What drugs are being tested in NCT04323241?

Interventions in NCT04323241: Controlled cord traction.

What condition does NCT04323241 study?

NCT04323241 studies Cesarean Section Complications.

Is NCT04323241 still recruiting?

NCT04323241 is currently completed. Last updated 4 February 2021.

Last reviewed 2021-02-04 · How we verify

NCT04323241

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Association of Placenta Removal Method and Postpartum Leucocytosis

Completed NA Last updated 4 February 2021

What this trial tests

NA trial testing Controlled cord traction in Cesarean Section Complications in 300 participants. Completed in 20 January 2021.

Timeline

1 October 2019

Primary endpoint
31 December 2020

20 January 2021

Quick facts

Lead sponsor	Haydarpasa Numune Training and Research Hospital
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	prevention
Enrollment	300
Start date	1 October 2019
Primary completion	31 December 2020
Estimated completion	20 January 2021
Sites	1 location across Turkey (Türkiye)

Drugs / interventions tested

Controlled cord traction

Conditions studied

Cesarean Section Complications — all drugs for Cesarean Section Complications →

Sponsor

Haydarpasa Numune Training and Research Hospital

Who can join

Adults 18 to 45, female only, with Cesarean Section Complications. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Cesarean delivery is one of the most common major abdominal operation in women worldwide. The incidence of postpartum infection has been estimated to be 1-4% after vaginal delivery and 10-20% after Cesarean delivery. Although it is widely performed, manual removal of the placenta is still a conflicting issue due to the risk of post-partum endometritis. All cesarean patients are randomized according to the removal of placenta from the uterus after childbirth; manually (Group 1) or controlled cord traction without putting fingers inside the uterus (Group 2). The aim of this study is to examine whether there is an association between the method of removal of the placenta and postpartum white blood cell increase in nonanemic, singleton, low-risk group of women with term pregnancies, who underwent elective cesarean delivery under general anesthesia.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Cesarean Section Complications

Currently open trials in the same condition.

NCT07278037 — Trends in the Administration of Tranexamic Acid for Postpartum Hemorrhage · recruiting
NCT05224726 — Platelet Rich Plasma for Uterine Scar · NA · recruiting
NCT07130747 — Effect of Myofascial Release Versus Deep Friction Massage on Abdominal Recovery and Scar After Cesarean Section · NA · recruiting
NCT05791630 — The Norwegian World Health Organisation Labour Care Guide Trial (NORWEL) · NA · recruiting
NCT07049705 — Factors Influencing Bradycardia During Spinal Anesthesia in Obstetric Patients Undergoing Cesarean Section · active not recruiting

Other Haydarpasa Numune Training and Research Hospital trials

Trials by the same sponsor.

NCT07495943 — Effects of 2-Aticyto Complex and D-Ribose on Pain and Clinical Course in Patients With Fibromyalgia · NA · not yet recruiting
NCT07433257 — The Effect of Local Corticosteroid Injection in Carpal Tunnel Syndrome Patients With Type 2 Diabetes · not yet recruiting
NCT07043335 — Comparison of the Efficacy of Mesotherapy and Extracorporeal Shock Wave Therapy in Patients With Lateral Epicondylitis · NA · recruiting
NCT07183774 — Does Sarcopenia Influence Rotator Cuff Tear Patterns? Radiological Insights From Patients With Rotator Cuff Syndrome · recruiting
NCT06918340 — Evaluation of Analgesic Efficacy of Lidocaine and Diclofenac Spray in Radial Artery Blood Gas Sampling by Visual Analogu · Phase 4 · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04323241 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Haydarpasa Numune Training and Research Hospital
Last refreshed: 4 February 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04323241.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing